CYTOSORBENTS CORP (CTSO)

US23283X2062 - Common Stock

0.88  +0.06 (+7.4%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
36.35M34.69M43.17M41.00M24.95M
Cost Of Goods
13.96M13.96M11.05M11.05M7.36M
Gross Profit
22.39M20.73M32.12M29.95M17.59M
Operating Expenses
52.67M52.25M54.86M40.32M36.56M
Research and Development
15.73M15.12M16.38M8.81M12.09M
Selling, General, and Administrative Expenses
36.94M37.14M38.48M31.51M24.47M
Operating Income
-30.27M-31.52M-22.74M-10.37M-18.97M
Interest Income/Expense
1.79M-2.32M-2.55M1.41M-1.38M
Other Income/Expense
96.75K-70.00KN/AN/AN/A
Non Recurring Items
-936.00KN/AN/AN/AN/A
Income Before Taxes
-29.32M-33.91M-25.29M-8.96M-20.36M
Income Tax
-813.74K-1.09M-740.00K-1.13M-1.09M
Net Income
-28.51M-32.81M-24.56M-7.84M-19.27M
EBITDA
-28.81M-30.64M-22.01M-9.71M-18.39M
 
Per Share Data
EPS Diluted Total Ops
-0.64-0.75-0.57-0.20-0.60
Non GAAP EPS
-0.65-0.76-0.57-0.20-0.59
 
Statistics
Gross Profit Margin
61.60%59.76%74.40%73.05%70.50%
Profit Margin
-78.43%-94.58%-56.89%-19.12%-77.23%
Operating Profit Margin
-83.28%-90.86%-52.68%-25.29%-76.03%

All data in USD

Charts